Low expression of MLKL is associated with poor prognosis in cervical squamous cell cancer [32], ovarian cancer [33], gastric cancer [34], and pancreatic adenocarcinoma [35]. This evidence concerns the gene MLKL and cervical squamous cell carcinoma.